Abbott Laboratories (ABT) Total Debt Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.99% |
| Dec 31, 2025 | -6.95% |
| Sep 30, 2025 | -6.75% |
| Jun 30, 2025 | -7.15% |
| Mar 31, 2025 | -6.03% |
| Dec 31, 2024 | -4.67% |
| Sep 30, 2024 | -4.54% |
| Jun 30, 2024 | -5.12% |
| Mar 31, 2024 | -5.00% |
| Dec 31, 2023 | -5.58% |
| Sep 30, 2023 | -4.45% |
| Jun 30, 2023 | -3.69% |
| Mar 31, 2023 | -4.84% |
| Dec 31, 2022 | -9.56% |
| Sep 30, 2022 | -6.94% |
| Jun 30, 2022 | -6.78% |
| Mar 31, 2022 | -6.38% |
| Dec 31, 2021 | -2.69% |
| Sep 30, 2021 | 24.94% |
| Jun 30, 2021 | 24.14% |
| Mar 31, 2021 | 15.55% |
| Dec 31, 2020 | 25.84% |
| Sep 30, 2020 | 17.14% |
| Jun 30, 2020 | 27.00% |
| Mar 31, 2020 | 15.34% |
| Dec 31, 2019 | 39.07% |
| Sep 30, 2019 | 18.47% |
| Jun 30, 2019 | 41.25% |
| Mar 31, 2019 | 40.90% |
| Dec 31, 2018 | 24.45% |
| Sep 30, 2018 | 19.50% |
| Jun 30, 2018 | 21.52% |
| Mar 31, 2018 | 42.06% |
| Dec 31, 2017 | 8.55% |
| Sep 30, 2017 | 12.46% |
| Jun 30, 2017 | 12.83% |
| Mar 31, 2017 | 13.02% |
| Dec 31, 2016 | 7.53% |
| Sep 30, 2016 | -18.56% |
| Jun 30, 2016 | -13.81% |
| Mar 31, 2016 | -13.02% |
| Dec 31, 2015 | -19.03% |
| Sep 30, 2015 | -11.27% |
| Jun 30, 2015 | -18.37% |
| Dec 31, 2014 | -21.38% |
| Sep 30, 2014 | -6.96% |
| Jun 30, 2014 | -21.45% |